Ketamine Addiction

What Is Ketamine Addiction?

Ketamine addiction is a pattern of compulsive ketamine use that persists despite significant physical, psychological, and social harm. Originally developed in 1962 as a rapid-acting anaesthetic, ketamine works primarily by blocking N-methyl-D-aspartate (NMDA) glutamate receptors in the brain, producing dose-dependent effects ranging from mild dissociation and euphoria at low doses to complete anaesthetic dissociation (the “K-hole”) at high doses.

The drug’s addiction profile is complicated by its recent emergence as a legitimate treatment for treatment-resistant depression, administered in controlled clinical settings as esketamine (Spravato). This therapeutic use has created a public perception that ketamine is “safe,” obscuring the reality that recreational misuse at uncontrolled doses carries serious addiction potential and devastating medical consequences. Research published in Addiction Biology indicates that approximately 20 percent of regular recreational ketamine users develop patterns consistent with substance use disorder within two years of regular use.

How Ketamine Addiction Develops

Ketamine’s addiction pathway differs from classical stimulant or opioid addiction because it acts primarily on the glutamate system rather than the dopamine system, although dopamine is indirectly involved.

Initial use and reinforcement: At sub-anaesthetic doses, ketamine produces a euphoric, dreamlike state with feelings of detachment from physical surroundings and emotional concerns. For individuals experiencing anxiety, depression, or emotional distress, this dissociative escape is powerfully reinforcing. The rapid onset (within minutes when insufflated) creates strong associative conditioning between use and relief.

Tolerance and escalation: NMDA receptor adaptation develops relatively quickly with regular use, requiring progressively higher doses to achieve the same dissociative effects. Users who initially consumed 50-100mg per session may escalate to multiple grams per day. This dose escalation dramatically increases both addiction severity and medical risk.

Psychological dependence: Ketamine addiction is driven heavily by psychological dependence rather than the severe physical withdrawal seen with opioids or alcohol. Users become reliant on the dissociative state as an emotional coping mechanism, using ketamine to escape stress, emotional pain, trauma, or simply boredom. The absence of dramatic physical withdrawal can actually delay treatment-seeking, as users underestimate the severity of their dependence.

Signs and Symptoms of Ketamine Addiction

Recognising ketamine addiction requires awareness of both behavioural changes and the distinctive physical complications that chronic use produces.

Medical Complications of Chronic Ketamine Use

Beyond the urological damage that is the hallmark of chronic ketamine misuse, the drug produces a range of systemic medical effects that distinguish it from most other recreational substances.

Hepatobiliary complications include elevated liver enzymes and biliary dilation, sometimes progressing to cholangitis. Neuroimaging studies of chronic ketamine users demonstrate white matter changes and cortical thinning, particularly in the prefrontal and parietal regions, correlating with the cognitive impairment observed clinically. Chronic use also disrupts the body’s pain processing systems, paradoxically increasing pain sensitivity (hyperalgesia) despite ketamine’s anaesthetic properties, and cardiovascular effects include hypertension and tachycardia that persist beyond acute intoxication in heavy users.

The cognitive effects are particularly concerning for younger users. Research published in Neuropsychopharmacology demonstrates measurable deficits in episodic memory, working memory, and executive function in chronic ketamine users, with some deficits persisting for months after cessation.

Treatment for Ketamine Addiction

Effective ketamine addiction treatment requires addressing the psychological dependence, managing any medical complications, and developing alternative coping strategies for the emotional states that drive use.

Medical assessment and stabilisation: Treatment begins with comprehensive medical evaluation, particularly urological assessment (including bladder capacity measurement and renal function tests) and liver function analysis. While ketamine withdrawal is not medically dangerous, symptoms including anxiety, insomnia, irritability, and cravings are managed supportively. Medications may include sleep aids for insomnia, and where urological damage exists, referral to urology for specialised management.

Psychological treatment: Cognitive-Behavioural Therapy (CBT) is the primary therapeutic modality, targeting the cognitive patterns that sustain dissociative drug seeking, particularly the use of ketamine as an emotional escape mechanism. Trauma-focused therapy is frequently indicated, as many chronic ketamine users are self-medicating unresolved trauma. Mindfulness-based interventions help patients develop tolerance for difficult emotional states without resorting to chemical dissociation.

When Substance Use Becomes More Than Occasional

Ketamine often enters a person’s life in social settings, used occasionally at parties or clubs with seemingly little consequence. The transition from occasional to habitual use can be gradual and difficult to recognise, particularly because ketamine does not produce the obvious physical dependence markers of opioids or alcohol.

Key warning signs that use has crossed into problematic territory include using ketamine alone rather than in social settings, using it to cope with stress or emotional pain rather than for recreation, finding that you need larger amounts to achieve the same effect, experiencing urinary symptoms, and continuing to use despite being aware of negative consequences. If these patterns are present, professional assessment is strongly recommended.

“The dissociative quality of ketamine makes it particularly insidious as an addictive substance. People are not just seeking a high; they are seeking an exit from emotional reality. Treatment must provide healthier pathways to emotional regulation, or the risk of relapse remains high regardless of how long someone has been abstinent.” — Dr. Ponlawat Pitsuwan

Frequently Asked Questions

Is ketamine physically addictive?

Ketamine produces primarily psychological rather than physical dependence. Unlike opioids or alcohol, stopping ketamine does not typically cause dangerous withdrawal symptoms. However, the psychological craving and habitual use patterns can be extremely difficult to break without professional support, and the absence of severe physical withdrawal should not be mistaken for absence of addiction.

Can ketamine bladder damage be reversed?

Early-stage bladder damage from ketamine use can partially or fully recover if ketamine use is stopped promptly. The bladder epithelium has some regenerative capacity, and cessation combined with medical management can restore significant function. However, advanced ketamine bladder syndrome with fibrosis and severe bladder contraction may be irreversible, potentially requiring surgical intervention. Early treatment is critical.

How is ketamine addiction different from other drug addictions?

Ketamine addiction is distinctive in several ways: it produces a unique dissociative rather than euphoric high, withdrawal is primarily psychological rather than physical, it carries specific urological risks not seen with other drugs, and the recent emergence of therapeutic ketamine has complicated public perception of its safety. Treatment approaches must address the specific emotional escape function that ketamine serves.

How does Phuket Island Rehab treat ketamine addiction?

Our programme begins with comprehensive medical assessment including urological evaluation, followed by medically supervised stabilisation. The core treatment combines CBT, trauma-focused therapy, and mindfulness-based interventions specifically designed for dissociative drug dependence. The residential setting in Phuket provides complete separation from the social environments that typically sustain ketamine use, while our clinical team has extensive experience with the specific challenges of ketamine recovery.

Clinical Reviewer: Dr. Ponlawat Pitsuwan, Physician | Publisher: Phuket Island Rehab | Last Updated: April 2026 | Clinical Entities: NMDA Receptor Antagonism, Dissociative Anaesthetic, Ketamine Bladder Syndrome, Ketamine-Induced Cystitis, Norketamine, Esketamine (Spravato), Cognitive-Behavioural Therapy, Trauma-Focused Therapy, Glutamate System, Biliary Dilation, White Matter Changes